On July 9, 2018, the Federal Drug Administration (FDA) held a public forum focusing on the patient’s perspective on drug development for chronic pain. The FDA invited members of the... read more →
The U.S. Department of Health and Human Services (HHS) has deemed May 12-16, 2016 National Neuropathy Awareness Week! The cornerstone of The Foundation for Peripheral Neuropathy's mission is to raise... read more →
On December 3, 2015, Astellas Pharma US, Inc. (the U.S. affiliate of Astellas Pharma Inc.), a R&D-driven global pharmaceutical company, invited the Foundation for Peripheral Neuropathy to present to a... read more →